Background & Aims: Treatment with tumor necrosis factor (TNF) induces murine hepatocyte apoptosis in vitro and in vivo when sensitizing concentrations of toxins are present. The aim of this study was to investigate whether endogenously formed TNF contributes to liver failure caused by hepatotoxins. Methods: The extent of liver damage, induced by a-amanitin or actinomycin D (ActD), was examined under various experimental conditions, preventing the action of TNF on hepatocytes. Results: TNF induced apoptosis of murine hepatocytes or human hepatoma cells in the presence of aamanitin or ActD. TNF and a-amanitin induced such hepatotoxicity also in vivo in a synergistic way. After in vivo administration of high doses of ActD or a-amanitin alone, hepatic TNF-messenger RNA was increased and hepatocytes underwent apoptosis. A neutralizing antiserum against TNF-a prevented the liver injury. Hepatotoxicity of ActD or a-amanitin also was prevented by pretreatment of mice with low doses of the tolerizing cytokine interleukin i. Mice deficient for the 55-kilodalton TNF receptor were protected from ActD-or a-amanitin-induced toxicity. Endotoxin-unresponsive C3H/HeJ mice also had liver failure after ActD treatment, and this damage was prevented by treatment with anti-TNF antiserum. Conclusions: Hepatotoxins such as a-amanitin may induce liver failure by an indirect mechanism involving sensitization of parenchymal cells toward endogenously produced TNF.
A poptosis and necrosis are two fundamentally diffcr-..l"1..ent modes of cell death.I,2 During adaptive processes to altered metabolic or physiological situations that arc not compatible with the survival of all cells within a tissue, apoptosis is the default demise.·" It is believed that necrosis follows when the insult to a tissue is so severe that the coordinated process of apoptotic death cannot be activated or the removal capacity for apoptotic cells is cxhausted. ' l,5 This notion is supported by the fact that apoptosis and necrosis may be induced by one and the same agent depending on the intensity of insult and that they may coexist or follow onc another during pathological situations.
4
,(,u-1O Often, the contribution of apoptosis to tissue injury may be underestimated or even overlooked because of efficient phagocytosis of apoptotic ce11s. 2 
,11
Traditionally, acute liver toxicity caused by xenobiotics has been described as predominantly necrotic as a consequence of a direct interaction between the toxin or its metabolites and the hepatocyte. 12 Several lines of evidence suggest that hepatotoxicity may be the result of primary apoptosis. For example, hepatotoxins such as paracetamol, cocaine, or nitrosamine have been shown to induce oligonucleosomal DNA fragmentation in viVO,P,'~15 and the formation of apoptotic bodies has been observed after treatment of animals with cocaine, l4 ethanol,16 dimethylnitrosaminel! n-galactosamine (GaIN), IS lead, 19 or thioacetamide. 9 Also, overstimulation of immunocompetent cells may play a relevant role in hepatotoxicity. Thus, liver nonparenchymal cells Of the mediators they release have been shown to modulate the hepatotoxicity of GaIN, diethyldithiocarbamate, phalloidin, acetaminophen, CC1 4 , and ethanol. In these cases toxicity was reduced or even prevented by the inactivation of liver macrophagcs or their secretory products. 2o - 28 These findings suggest that highly regulated, receptor-operated processes arc part of the hepatotoxic mechanism of classical xenobiotics. The liver irself harbors the largest pool of macrophages in the body, and it may indeed release large amounts of tumor necrosis factor (TNF) after stimulation with lipopOlysaccharide (LPS). 29 For these reasons, we examined whether endogenous TNF may be involved in livet damage induced by putatively "direct" hepatotoxins. We chose two model compounds that cause a transcriptional block within the target cell as well-described mechanism of action. ActD is a toxin known to interact with exogenous TNF, whereas (X.-amanitin was chosen because of its history in human poisoning as a mushroom component that induces severe hepatic failure after ingestion.37~-11 In addition, we considered hepatocyte apoptosis after in vivo administration of the pure toxins.
Materials and Methods

Materials
Tissue culture material was obtained from Nunc (Wiesbaden, Germany), media and supplements were obtained from GIBCO (Eggcnstein, Germany), and serum for cell culture was purchased from Biochrom (Berlin, Germany). Recombinant TNF-cx was provided generously by Dc G. R. Adolf, Bender & Co. (Vienna, Austria), and rhuIL-l~ was obtained from Ciba-Geigy (Basel, Switzerland). Saimonella abortll5 eq1li endotoxin (LPS) was purchased from Sebak (Aidenbach, Germany). n X 123-base pair molecular weight marker was obtained from GIBCO. An immunoglobulin (Ig) G fraction of ovine anti murine TNF-cx antiserum was prepared as described. 36 Unless furthcr specified, all other reagents, e.g., cxamanitin (endotoxin content :5:2 ng/mg), were purchased from Sigma Chemical Co. (Deisenhofen, Germany).
Animals
Specific pathogen-free male BALBIc or C57BL mice (25 g) were obtained from the internal animal brceding house, University of Konstanz, Germany. A breeding stock of 55-kilodalron TNF receptor (CD121 a)-deficient mice 42 
Protein and RNA SyntheSiS
For the determination of protein or RNA synthesis the label (S.4 X 10' Bq ('H)uridine or 1.S5 X 10' Bg CH)leucine) was added in a volume of 10 M-L to hepatocytes in 24-well plates. After 2 hours, the medium was removed and cells were washed three times with ice-cold 10% trichloroacetic acid (wtl vol) and dried with methanol at -20°C. Then they were lysed for S-12 hours at 37°C with 300 jJ.L 0.5 moUL NaOH/1 mmollL ethylenediaminetetraacetic acid (EDTA)/O.l % Triton.
An aliquot of 250 J.lL waS used for detection of acid-precipitable radioactivity by ~-scjntillation counting. Ten microliters of the remaining lysis buffer was diluted 30-fold and used for protein dctermination. 43 Typically, with 10 I1mollL cxamanitin hepatocyte RNA synthesis was reduced to <50% within 15 minutes and protein synthesis decreased to <20% (compared with untreated controls) within 18 hours (50% after 6 hours).
In Vivo Experiments
AcrD (0.8-3.2 mg/kg) or <x-amaoitin (0.8-4.5 mg/ kg) were injected intraperitoneally in 500 J.lL of saline. Ami-TNF IgG (sufficient to neutralize TNF serum concentrations of 100 ng/mL) was given in a volume of 200 ilL intravenously at the time points indicated, and rhuIL-l~ was given intravenously 4 hours before the toxin challenge. Aftcr anesthesia, samples were obtained from mice by intravenous injection of 150 mg/kg pentobarbital plus 0.8 mg/kg heparin. Blood was withdrawn by cardiac puncture and immediately centrifuged for 2 minutes at 4°C at 13,000g to obtain the plasma. Livers were perfused for 10 seconds with cold perfusion buffer (50 mmollL phosphate, 120 mmollL NaCl, aod 10 mmoUL EDTA, pH 7.4) and subsequently cxcised. A slice of the large anterior lobe was immersed immediately in 4% formalin solution as a fixation for histological studies. For RNA preparation, a liver sample (approximately 50 mg of protein) was fixed immediately in buffer (4 molJL guanidine-isothiocyanate, 25 mmolJL sodium citrate, 0.5% lauroyl sarcosine, and 100 mmolJL ~ mercaptoetbanol). For determination of DNA fragmentation, the liver was homogenized. A fixed volume of the 20% homogenate (in perfusion buffer) was centrifuged at 13,OOOg for 20 minutes. The supernatant was used to detect DNA fragmentation by enzyme-linked immunosorbeot assay (ELISA), or DNA was precipitated with ethanol (-20°C) plus sodium acetate (150 mmolJL final concentration) and stored at -20°C for further analysis of oligonucleosomaI DNA fragmentation on agarose gels.
Hepatoma Cell Culture
Human hepatoma cell' (HepG2, ATCC ]]88065) were cultured routinely in RPMI 1640 supplemented with 5% fetal calf serum, 100 U/mL penicillin, 100 ~g/mL streptomycin, and 2 mmollL alanyl-glutamine at 37°C under a 5% CO 2 atmosphere. Cells were harvested by treatment with 25 mg! mL trypsin plus EDTA (GIBCO) for 4 minutes followed by vigorous tapping of the culture flask. Viability of the detached cells exceeded 95% as determined by trypan blue exclusion. Under normal growth conditions, cells had a doubling time of 20 hours. For toxicity experiments, cells were seeded in 24-well tissue culture plates at a density of 2.5 X 10s/mL and grown for 36 hours. The growth medium was then removed and cells were exposed in 500 ~L of RPMI 1640.
Hepatocyte Cultures
Hepatocytes were isolated according to Seglenf,f, with an initial viability exceeding 80% as determined by the trypan blue exclusion method. Hepatocytes (8 X 10" cells/well) were plated in 200 ~L of RPMI ] 640 medium containing 10% newborn calf serum in 24-well plates. They were allowed to adhere to culture plates for 5 hours before the medium was exchanged for set'Um-free RPMI 1640. TNF was added 30 minutes after the medium change. ActD or CX-amanitin were added directly after the medium change. Experiments were performed at 37°C in an atmosphere composed of 5% CO 2 / 40% O 2 /55% N2 for the times indicated.
Cytokine Determination
Samples for determinations of TNF bioactivity or protein content were immediately frozen at -20°C until analysis in the WEHI 164 bioassay45 or by ELISA. 46 Quantitative polymerase chain reaction (PCR) for determination of hepatic TNF, interferon (IFN) y, and interleukin (lL) 6 messenger RNA (mRNA) levels was performed as follows 46 : total tissue RNA (1 ~g) was reverse transcribed in a volume of 20 ilL using random primers and murine Moloney leukemia virus reverse transcriptase according to the supplier's recommendation (GIBCO/BRL, Eggenheim, Germany). Cytokine-specific mRNA expression was quantified by PCR, using a multispecific control fragment as internal standard. 47 Known amounts of control fragment were added in different dilutions to unknown fixed amounts of complementary DNA (cDNA) for competitive coamplification with specific primers. The proportion of peR products amplified from the control fragment and target cDNA was estimated after separation on 1.5% agarose gels measuring the intensity of ethidium bromide fluorescence by a eCD image sensor and analyzed using the EASY program (Herolab, Wiesloch, Germany). First, the various cDNA samples to be compared were equilibrated according to their ~-actin cDNA content. Then, the relative concentration of cytokine cDNA was estimated in each sample from the concentration of the control fragment DNA, which achieved equilibrium between its own amplification and the amplification of the cytokine cDNA. The concentrations were expressed in arbitrary units (AUs). One AU was defined as the lowest concentration of control fragment that yielded a detectable amplification product given the primer pairs and PCR conditions 
Cytotoxicity and DNA Fragmentation
Lactate debydrogenase 4 !l was determined in culture supernatants, and in the remaining cell monolayer after lysis with 0.1 % Triton X-100. The percentage of lactate dehydrogenase release was calculated from the ratio of S/(S + C), where 5 is culture supernatant and C is the remaining cell monolayer. Alternatively, the capacity to produce formazan from 3-(4,5-dimethyl-thiazol-2-yl)-3,5-diphenyltetrazolium bromide was measured as described recently .. '16 Hepatocytolysis in vivo was determined by measuring the plasma activities of alanine aminotransferase (ALT), aspartate aminotransferase (AST), and sorbitol debydrogenase (SDH).4!l DNA fragmentation io HepG2 cultures or in murine livers was quantitated by measuring cytosolic oligonucleosome-bound DNA using an ELISA kit (Boehringer, Mannheim, Germany) as dcscribed. 49 As antigen source we used either the cytosolic fraction (13,000g supernatant) of about 150 cultured hepatocytes or the cyrosolic fraction from about 75 ~g liver tissue. Also, DNA fragmentation was analyzed semiquantitatively after extraction of low-molecularweight DNA by the phenollchloroform method from the 13,000g supernatant obtained from either 30 mg liver tissue or 2 X 10 5 cultured hepatocytes. For analysis on 1. 0% agarose gels DNA was precipitated by ethanol. Bands in the gel were stained with SYBR-green (Molecular Probes, Eugene, OR), visualized by UV illumination (312 om), and photographed with Polaroid film (Eastman Kodak Co., New Haven, CT).
Morphology
Liver cell cultures were either stained with 2 ~g/mL H-33342 for 6 minutes directly, or they were first fixed with 80% methanol (~20°C) and then stained with 5 Jlg/mL propidium iodide. The number of apoptotic nuclei was scored under the fluorescence microscope.
Livers were fixed for histological examination 12, 16, 20, and 24 hours after the challenge and imbedded in paraplast. Sections (3-5 Ilm) were stained with H&E, and photomicrographs were taken on a Leica DM-JRB microscope (Leica Lasertechnik GmbH, Hcidelberg, Germany) equipped with a lOOX/NA 1.2 lens.
Statistics
All experiments with cell culture were repeated in at least three different cell preparations. Statistical differences were determined by an unpaired t test if applicable or with the unpaired Welch test (in the Case of inhomogeneous variaoces).
Results
Facilitation of TNF-Induced Apoptosis in Human Hepatoma Cells by Toxins
Various transcriptional inhibitors, including ActD and the fungal toxin a-amanitin, have been shown to sensitize murine hepatocytes toward TNF-induced apoprosis. 49 We examined whether similar results would be obtained with human liver cells and therefore used the HepG2 hepatoma line, usuaUy not sensitive toward TNF alone,50,51 As in murine hepatocytes, (X,-amanitin alone (:550 J.LmollL) or AcrO alone (400 nmollL) showed no toxicity. However, the toxins dramatically sensitized the cells toward TNF toxicity (Figure 1) . The mode of cell death was apoptotic, judged from observations of the nuclear morphology (not shown) and from the fact that oligonucleosomal DNA fragmentation clearly preceded membrane lysis (Figure 1) . Thus, various toxins seem to facilitate the well-known induction of apoptosis in human liver cells as well as in murine hepatocytes. This synergism of TNF and toxins may explain the highly hepatotoxic potential of a-amanitin in vivo despite the seemingly low sensitivity of hepatocytes in vitro.
Synergistic Toxicity of a-Amanitin and TNF In Vivo
To investigate whether the synergistic toxicity of TNF and a-amanitin would in fact occur in vivo, we injected mice with a combinarion of these agents and determined the time course of DNA fragmentation and hepatocytolysis in these animals ( Figure 2 ). The concentrations ofTNp 52 and cx'-amanitin were within a nontoxic range, if administeted alone. In agreement with our in vitro results, the combined treatment caused fulminant liver failure, as characterized by massive release of liver enzymes between 5 and 8 hours after the challenge. As expected for a pathological sequence associated with early apoptosis, hepatic DNA fragmentation preceded hepatocytolysis. On the basis of these results we then tested whether cx'-amanitin or related toxins may induce liver failure by sensitization of hepatocytes toward endogenously released TNF.
Prevention of ActD or a-Amanitin Toxicity by Neutralization of Endogenous TNF
Injection of 0.8 mg/kg ActO, a dose suitable to sensitize animals toward TNP49 during fulminant shortterm (8 hours) experiments, was well tolerated by animals over a period of24 hours. However, increasing the dose to 1.6 mg/kg was sufficient to elicit fulminant liver failure within 24 hours without concomitant injection of exogenous TNF. This toxicity was prevented by neutralization of endogenous TNF. Also, the toxicity elicited by a higher dose of AcrO (3.2 mg/kg) was reduced drastically by passive immunization of mice against TNP (Pigure 3A), whereas conrrol IgG had no significant effect (Table  1) . We then examined whether a single administration of cx-amanitin doses greater than those used for the TNF sensitization in vivo would cause a TNF-dependenr hepatotoxicity. Doses of cx-amanitin greater than 2 mg/kg induced fulminant hepatic failure, which was blocked by neutralization of endogenous TNF ( Figure .3£3 ). Both ActD and cx-amanitin strongly sensitize mice toward LPS.,:)t Notably, the toxins used in this study were essentially endotoxin-free as determined by the limulus assay. In complementary experiments we examined the toxicity of ActD in C3H/HcJ mice that are resistant to endotoxin. 5 .) These mice also developed liver damage 24 hours after ActD challenge, which was comparable in its extent to the o~e observed in the LPS-sensitive control strain (C3H/HcN) and also was reduced significanrly by passive immunization against TNF (Table 1 ). In addition, we injected anci-TNF IgG 60 minutes after the toxin challenge. In LPS models this time point is coincident with the peak of the TNF production 54 and represents a stage where complete protection by TNF neutralization is no longer possible. However, mice challenged with CX-amanitin or AccD were protected by this delayed protocol as efficiently a<; if the antibody was giveo before the challenge. Therefore we assume that TNF was produced slowly in this model unlike after treatment of mice with endotoxins.
To get direct evidence on putative cytOkine production, we checked whether cytokine mRNAs were upregulated in the target organ itself, i.e., the liver. AccD increased TNF, IFN-y (Figure 4) , and IL-6 (not shown) mRNA levels significantly within 7 hours. Treatment with cx-amanitin caused an increase of mRNAs, which was statistically significant in the case of IFN-y. Thus immunologically mediated toxicity of the hepatotoxins used for this study may in fact be explained by the upregulation of inflammatory cytokines. Finally, we sampled serum at various times to measure TNF that may have been released from the site of production ioco the circulation. At different times up to 10 hours after the challenge we neither detected TNF bioactivity nor TNI' protein in the plasma. This might have been caused by a restriction of TNF production and action to local sites.
Inhibition of ActO or a-Amanitin Toxicity by Prevention of Actions of Endogenous TNF
To get further insights on the role ofTNF in the hepatotoxic actions of ActD or CX-amanitin, we used two different approaches. First, we examined the toxicity of these substances in mice deficient for either TNF I'eceptor. Hepatotoxicity was only observed in mice having a functional 55-kilodalton TNF receptor, in accordance with the fact that this receptor is obligatory for inducing direct TNP-induced tOxicity in sensitized hepatocytes.3<; Mice lacking the 75-kilodalton TNF receptoI' were not protected from rhe toxins ( Table 1) .
A second approach consisted of the desensitization of mice against the hepatotoxic effects of TNF by pretreatment with IL_1.55 Also, this immunological intervention against TNF toxicity prevented completely the hepatotoxicity of cx--amanitin or AccD, respeccively (Table 1) 
Hepatocyte Apoptosis in ActD or (lAmanitin Toxicity
Our in vitro data and the evidence from the in vivo experiments suggest that cytokincs may contribute to toxic liver failure by the induction of hepatocyte apoptosis. Thus, we followed the time course of DNA fragmentation and cell lysis after treatment of mice with the hcpatotoxins (Figure 5A ). In both experimental models alanine aminotransferase release as a parameter of loss of membrane integrity was preceded by DNA fragmentation, i.e., an indicator for apoptotic cell death. We verified the occurcnce of apoptosis by two further approaches. First, we investigated whether DNA fragmentation was of the oligonucleosomal type (Figure 58 and C) . Indeed, a distinct ladJering of DNA was observed on analysis on agarose gels already ] 2 hours after the chaUenge in livers derived from mice that had no significantly elevated plasma transaminase activities.
Second, we examined the histological alterations after injection of (X-amanitin or ActD, respectively ( Figure 6 ). The most conspicuous change 12 hours after injection of either toxin was the appearance of individual strongly eosinophilic cells with hyperchromatic nuclei that were condensed, had marginated lumpy c1uo-matin, and adopted an elipsoid shape. Neutrophil invasion or hemorrhage was minimal or undetectable. Eosinophilic hepatocytes, indicating an early stage of apoptosis, were sometimes organized in small patches. About 16 hours after injection of (X-amanitin, strongly shrunken nuclei and distinct apoptotic bodies were detectable. At later time points polymorphonuclear leukocyte invasion was marked and necrotic foci appeared, partially associated with hemorrhages. Some hepatocytes displayed macrovesicular vacuolization and karyolysis. The structural organization of the lobes was preserved largely and the numbers of strongly condensed hyperchromatic nuclei and apoptotic bodies were increased. After ActD application changes were similar but occurred more rapidly.
Discussion
The results of this study strongly suggest that endogenous TNF and the induction of hepatocyte apoptosis are key phenomena in the hepatotoxicity of ActD or (X-amanitin in mice. Either of the two toxins is commonly assumed to inhibit transcription of mamma- -'Anti·TNF IgG was injected 10 minutes before the toxin challenge. bAnti-TNF IgG was injected 60 minutes after the tOXin challenge. 'Serum was withdrawn 24 hours after tile challenge. dp ~_: 0.05. ---- lian cells nonselcctively and the selective hepatotoxicity of cx-amanitin in humans has been explained previously mainly by pharmacokinetic properties. Our data provide a different rationale for the mechanism ,of toxicity of these compounds: the induction of hepatocyte apoptosis and the subsequent liver necrosis may result from a synergistic action with endogenous TNF. This agrees with and extends previous findings that a liver-specific transcriptional inhibitor, l.e., GaIN, induces hepatic apoptosis and necrosis in syncrgy with endogenous TNI' when coadministercd with LPS,52 and that the unspecific transcriptional inhibitor ActD induced hepatic apoptosis syner,f5istically with exogenous TNF.'i9 TNF has different activities, depending on the cell type and the metabolic situation of the ceH, i.e., it x n--bp rnolecular weight marker. ID conjunction with ActD or cycloheximide.-1 9 ,51 To firmly establish that the mechanisms in these human cells were similar to those observed in murine hepatocyres, the mode of cell death was put under scrutiny.
Morphological changes as well as the rime course of cell lysis vs. DNA fragmentation suggest that the events of cell death were similar to those observed in murine hepatocytes in vitro. It may be speculated that the basis of our in vivo findings in mice may be extrapolated to the human situation. Although the direct molecular targers of ActD and [iamanitin are different, their overall action is strikingly similar. As in the case of ActD,49 a reduction of transcription by about 50% is sufficient to sensitize a-amanitintreated cells toward TNF-induccd apoptosis. If impairment of transcription or translation is indeed a general mechanism to sensitize the liver toward the toxicity of endogenous TNF, then the action of many different toxins may involve this principle of toxicity.GO Different toxins such as diethylnitrosaminc, CCl ti , 12 and Pseudomonas aeruginosa exotoxin 61 have been shown to impair partially protein synthesis; therefore, they may eventually cause liver damage synergistically with TNF.
In our experience, it seems that at least two factors confound a direct linear relationship between the extent of a protein synthesis block and TNF-induced apoptosis. First, a complete shutdown of protein synthesis would also inhibit the de novo synthesis of endogenous TNF. The relevance of this phenomenon may be indicated by the fact that the dose-response curves for the two toxins used in this study were consistently bell-shaped ( Figure  3 ; data not shown). Supportive evidence COmes also from findings that cycloheximide is a poor sensitizer for TNF in hepatocytes and may even protect under certain situations. 6
? Alw, complete arrest of protein synthesis by cycloheximide, puromycin, or ricin was shown to prevent the apoptotic action of TNF. 49 Although our experiments with gene-targeted mice and a specific antiserum against TNF provide strong evidence for the involvement of endogenous TNF in the toxicity of ActD or a-amanitin, we deemed it important to show that endogenous mediators could be produced under such experimental situations. The fact that we found increases of different cytokine mRNAs in the liver indicates that an augmentation of the respective mRNA pool was still possible and may have allowed enhanced production of different peptide mediators. In addition, in the case of TNF it has been shown that macrophages in the presence of ActD released increased amounts of TNF spontaneously and upon stimulation with endotoxin. 63 ,M We found that LPS stimulated the subsequent release of TNF from murine Kupffer cells (l0 ngll 0' macrophages after 5 hours) up to 30 minutes after preincubation with AnD. An explanation for these observations may be a posttranscriptional regulation of TNF synthesis. 65 Circulating cytokines can only be detected in serum when there is a massive overflow at the local site of production, which was obviously not the case in our models. Several agents cause tolerance toward a subsequent LPS challenge, by suppressing cytokine production. 66 IL-1 differs from this insofar as pretreatment with this cytokine selectively prevents TNF-induced apoptosis 55 (but not CD95-induced apoptosisti), i.e., it protects the target organ from the terminal mediator of toxicity. Protection of mice from a-amanitin or ActD by IL-1 pretreatment provides an independent line of evidence for the involvement of indirect immune mechanisms in the hepatotoxicity of these agents.
The question of why such detrimental immune mechanisms are activated by toxins cannot be answered by this study. It is established that hepatocytes possess several independent pathways to initiate apoptosis. However, it is not clear whether all deaths arc mediated by neighboring cells (Kupffer cells or orher hepatocytes), by soluble cytokines, or even by autocrine mechanisms, because hepatocytes themselves may acquire the capacity to synthesiLe cytokines such as IL-] 67 gra t reJectIOn, VIra lfilectIOn,' an overstimulation of the immune response),-19,7.1-n into a limited number of apoptotic pathways may allow the liver to react in a controlled way without loss of tissue organization, unless the stimulus becomes strong enough to activate secondary processes leading to necrosis and inflammation. The latter case may occur in toxicological model systems like the one used in this study or after ingestion of large amounts of hepatotoxins (e.g., fungal poisoning), but it may represent an exception to the rule that small percentages of cells affected under less severe conditions are removed silently by apoptosis.
To summarize our findings diagrammatically ( Figure  7) , we suggest two different principles of action for the in vivo toxicity of hepatotoxins. They may directly damage parenchymal cells according to well-established cytotoxic mechanisms deducible from a plethora of in vitro studies. Such damage may both sensitize cells to the attack of cytokines and be the basis for the release of cytokines. Second, they may cause the overproduction of cytokines by allowing LPS mobilization from the intestine,25,78 by inducing the formation of local inflammatory foci, or by a direct, yet unknown, interaction with the cytokineproducing cells. The synergistic action of endogenous cytokines such as TNF with xenobiotic-sensitized cells may be the final cause of liver failure as shown in the case of ActD or u-amanitin.
